Search Login Register

Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight) Summary

Description: Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.

Also Known As: Heparin, Low Molecular Weight; Heparin, Low-Molecular-Weight; Low Molecular Weight Heparin; LMWH

Networked: 3085 relevant articles (437 outcomes, 717 trials/studies) for this Bio-Agent

Key Diseases for which Low-Molecular-Weight Heparin is Relevant

  1. Venous Thrombosis (Deep-Vein Thrombosis) : 101 outcomes 172 studies in 691 results
  2. Venous Thromboembolism : 80 outcomes 116 studies in 447 results
  3. Hemorrhage : 56 outcomes 97 studies in 500 results
  4. Neoplasms (Cancer) : 51 outcomes 79 studies in 246 results
  5. Thrombosis (Thrombus) : 43 outcomes 78 studies in 460 results
Show All >>

Drugs Related to Low-Molecular-Weight Heparin

  1. Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
  2. Heparin (Liquaemin)
  3. Enoxaparin (Lovenox)
  4. Dalteparin (Dalteparin Sodium)
  5. Warfarin (Coumadin)
  6. Aspirin (Acetylsalicylic Acid)
  7. fondaparinux (Arixtra)
  8. Anticoagulants
  9. Vitamin K
  10. Platelet Membrane Glycoprotein IIb
Show All >>

Therapies Related to Low-Molecular-Weight Heparin

  1. Renal Dialysis (Hemodialysis)
  2. Arthroplasty
  3. Hip Replacement Arthroplasty (Total Hip Replacement)
  4. Compression Stockings
  5. Thrombolytic Therapy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2010 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.